13F HOLDINGS REPORT
HealthInvest Partners AB
Quarter ended Q2 2024 · Filed August 14, 2024 · Accession 0001381843-24-000006
Total Value
$164.0M
Positions
38
Other Managers
0
Confidential Omitted
No
Holdings (38)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ELI LILLY & CO | LLY | 27,144 | $24.6M | 14.98% |
| 2 | UFP TECHNOLOGIES INC | UNH | 31,680 | $16.1M | 9.84% |
| 3 | MERCK & CO INC | MRK | 112,734 | $14.0M | 8.51% |
| 4 | THERMO FISHER SCIENTIFIC INC | TMO | 19,458 | $10.8M | 6.56% |
| 5 | AMGEN INC | AMGN | 27,589 | $8.6M | 5.26% |
| 6 | BOSTON SCIENTIFIC CORP | BSX | 106,557 | $8.2M | 5.00% |
| 7 | REGENERON PHARMACEUTICALS | REGN | 6,893 | $7.2M | 4.42% |
| 8 | VERTEX PHARMACEUTICALS INC | VRTX | 15,095 | $7.1M | 4.31% |
| 9 | CENCORA INC | COR | 30,320 | $6.8M | 4.17% |
| 10 | STRYKER CORPORATION | SYK | 19,983 | $6.8M | 4.15% |
| 11 | ABBVIE INC | ABBV | 35,618 | $6.1M | 3.73% |
| 12 | DEXCOM INC | DXCM | 34,483 | $3.9M | 2.38% |
| 13 | EDWARDS LIFESCIENCES CORP | EW | 36,505 | $3.4M | 2.06% |
| 14 | NEUROCRINE BIOSCIENCES INC | NBIX | 23,630 | $3.3M | 1.98% |
| 15 | IQVIA HLDGS INC | IQV | 13,984 | $3.0M | 1.80% |
| 16 | MOLINA HEALTHCARE INC | MOH | 9,500 | $2.8M | 1.72% |
| 17 | CARDINAL HEALTH INC | CAH | 27,500 | $2.7M | 1.65% |
| 18 | UFP TECHNOLOGIES INC | UFPT | 9,800 | $2.6M | 1.58% |
| 19 | MIRUM PHARMACEUTICALS INC | MIRM | 75,200 | $2.6M | 1.57% |
| 20 | INTRA-CELLULAR THERAPIES INC | 46116X101 | 35,841 | $2.5M | 1.50% |
| 21 | IONIS PHARMACEUTICALS INC | IONS | 40,691 | $1.9M | 1.18% |
| 22 | MERUS N V | N5749R100 | 30,837 | $1.8M | 1.11% |
| 23 | CORBUS PHARMACEUTICALS HLDGS | CRBP | 39,100 | $1.8M | 1.08% |
| 24 | ALKERMES PLC | ALKS | 68,800 | $1.7M | 1.01% |
| 25 | OPTION CARE HEALTH INC | OPCH | 54,395 | $1.5M | 0.92% |
| 26 | AMICUS THERAPEUTICS INC | FOLD | 148,207 | $1.5M | 0.90% |
| 27 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 75,794 | $1.5M | 0.89% |
| 28 | KRYSTAL BIOTECH INC | KRYS | 7,624 | $1.4M | 0.85% |
| 29 | BRIDGEBIO PHARMA INC | BBIO | 53,432 | $1.4M | 0.83% |
| 30 | ARCELLX INC | ACLX | 22,496 | $1.2M | 0.76% |
| 31 | HARMONY BIOSCIENCES HLDGS IN | HRMY | 34,900 | $1.1M | 0.64% |
| 32 | IMMUNOCORE HLDGS PLC | IMCR | 23,778 | $805,836 | 0.49% |
| 33 | AUTOLUS THERAPEUTICS PLC | AUTL | 226,145 | $786,984 | 0.48% |
| 34 | MORPHIC HLDG INC | 61775R105 | 20,199 | $688,179 | 0.42% |
| 35 | PHARVARIS N V | PHVS | 34,328 | $645,366 | 0.39% |
| 36 | MACROGENICS INC | MGNX | 143,407 | $609,479 | 0.37% |
| 37 | CABALETTA BIO INC | CABA | 64,321 | $481,121 | 0.29% |
| 38 | MERSANA THERAPEUTICS INC | 59045L106 | 184,900 | $371,649 | 0.23% |